Background {#Sec1}
==========

Sepsis is a life-threatening complication of infection and characterized by physiologic, pathologic, and biochemical abnormalities \[[@CR1], [@CR2]\]. It is the tenth-most-common cause of death globally \[[@CR3]\] and the most common cause of death in patients with infections, especially when sepsis is not identified and treated promptly. Early treatment of sepsis improves patients' mortality and outcome \[[@CR1]\].

Serum lactate level is a sensitive but nonspecific indicator of metabolic stress \[[@CR4]\]. As a product of anaerobic glycolysis, lactate is increased during hypoxia, stress and many critical illnesses \[[@CR5]\]. Recent research presents a positive association between higher levels of lactate and increased mortality \[[@CR6]\]; the higher the lactate level, the worse the outcome \[[@CR7]\]. Different lactate thresholds have been recommended in some studies as an early aggressive resuscitation predictor \[[@CR7]--[@CR12]\]. Based on this, early identification of elevated serum lactate levels can potentially lead to early identification of patients who are in danger of poor outcomes. Sequential Organ Failure Assessment (SOFA) \[[@CR13]\] and quick SOFA (qSOFA) \[[@CR1], [@CR14]\] were designed to measure organ dysfunction in patients admitted to intensive care units (ICU). We further explored the prognostic accuracy of the serum lactate level, the SOFA and the qSOFA in predicting mortality in patients with sepsis.

Materials and methods {#Sec2}
=====================

Data source {#Sec3}
-----------

The data used in this study were collected from Medical Information Mart for Intensive Care III database version 1.4 (MIMIC III v1.4), a publicly available single-center critical care database. It includes information on 46,520 patients who were admitted to the ICU of Beth Israel Deaconess Medical Center in Boston, Massachusetts from 2001 to 2012 \[[@CR15]\]. The database documents included charted events such as demographics, vital signs, laboratory tests, fluid balance and vital status. International Classification of Diseases, Ninth Revision (ICD-9) codes were also documented by hospital staff on patient discharge. Hourly physiologic data from bedside monitors validated by ICU nurses were recorded. Written evaluations of radiologic films by specialists covering in the corresponding time period were stored in the database. The documentation in the database was provided by clinicians, data scientists, information technology personnel and users \[[@CR15], [@CR16]\]. The project was approved by the institutional review boards of the Massachusetts Institute of Technology (MIT) and Beth Israel Deaconess Medical Center (BIDMC); there was no requirement for individual patient consent because unidentified health information of patients was used. The raw data were extracted using structure query language (SQL) with Navicat Premium version 12.0.28 and further processed with R software (version 3.4.3, CRAN). The code that supports the MIMIC-III documentation and website is publicly available, and contributions from the community of users are encouraged (<https://github.com/MIT-LCP/mimic-website>). The codes used to generate the descriptive statistics are included in a notebook that is available at: <https://github.com/MIT-LCP/mimic-iii-paper/> \[[@CR15]\].

Data extraction and management {#Sec4}
------------------------------

We obtained the related information on patients who were diagnosed with "sepsis", "severe sepsis" and "septic shock" on discharge. A total of 3713 sepsis patients were included. Variables with missing data are common in the MIMIC III database. We excluded patients with missing data (patients without documented lactate or main laboratory tests including hemoglobin, albumin, WBC, bilirubin, BUN, potassium, sodium, bicarbonate, Cr, platelet analyzed in Table [2](#Tab2){ref-type="table"} in first 24 h from ICU admission were excluded) and patients less than 18 years of age, 1865 patients in our cohort finally met the inclusion criteria in our cohort. The detailed process of data extraction is shown in Fig. [1](#Fig1){ref-type="fig"}. We collected the following data: baseline demographic information such as age, sex, weight, and ethnicity; clinical parameters including vital signs, hospital stay, ICU stay, and survival status; laboratory tests and scores on disease scoring systems including Sequential Organ Failure Assessment (SOFA) (Additional file [8](#MOESM8){ref-type="media"}: Table S1) \[[@CR13]\], quick SOFA (qSOFA) Additional file [9](#MOESM9){ref-type="media"}: Table S2) \[[@CR1], [@CR14]\], and the Glasgow Coma Scale (GCS) \[[@CR17]\]. We retrieved the SQL scripts from the github website (<https://github.com/MIT-LCP/mimic-code/tree/master/concepts/severityscores>) and used them to calculate the severity scores. The SOFA, qSOFA and GCS scores of the patients were calculated based on the data obtained during the first 24 h of each patient's ICU's stay; the scores represent the worst scores during the first 24 h of ICU admission. The lactate level measured during the first 24 h of ICU admission was used in this study. If lactate was measured multiple times in the first 24 h, the average lactate level was used in our study.Fig. 1The detailed process of data extraction

Statistical analysis {#Sec5}
--------------------

Lactate was divided into two groups based on the cut-off value (3.225 mmol/L) which was determined by receiver operating characteristic (ROC) curve analysis \[[@CR18]\]. Lactate group 1 included patients with lactate \< 3.225 mmol/L, and lactate group 2 included patients with lactate ≥3.225 mmol/L. Other continuous variables were categorized and divided into groups of equal size based on the number of patients. Normally and non-normally distributed continuous variables were summarized as the mean ± SD and as the median with interquartile range (IQR), respectively. The Shapiro-Wilk test and the Kruskal Wallis test were used to assess significant differences. Categorical variables were assessed using chi-square test or Fisher's exact test. Kaplan-Meier curves were analysed using log-rank tests. The Cox regression model was used to analyse the independent effects of various parameters on 30-day mortality. All the analyses were conducted using R software (version 3.4.3, CRAN), SPSS software (v20.0; IBM, Armonk, NY), MedCalc Statistical Software (v15.2.2; MedCalc Software bvba, Ostend, Belgium) and PASS software (v15; NCSS Statistical Software, Kaysville, Utah, USA); a *P* values\< 0.05 represents statistical significance.

Results {#Sec6}
=======

Baseline characteristics and outcomes {#Sec7}
-------------------------------------

A total of 1865 sepsis patients are included in this study. The baseline characteristics, vital signs, laboratory parameters and outcomes of the patients are summarized in Table [1](#Tab1){ref-type="table"}. The lactate levels of patients in between lactate group 1 and lactate group 2 differ significantly (median 2.05 mmol/L vs. 4.95 mmol/L, *p* \< 0.001). Patients with lower lactate have better outcomes (30-day mortality, 33.88% vs. 59.23%; 90-day mortality, 43.57% vs.67.81%; 1-year mortality, 51.46% vs. 71.39%; in-hospital mortality, 34.99% vs. 60.80%; overall mortality, 60.12% vs. 77.97%) and lower SOFA scores (median 7 vs. 11, p \< 0.001), and a lower proportion of these patients have qSOFA scores of 2 or more points (84.48% vs. 91.99%). In our cohort, lactate levels show no correlation with severe sepsis rate (96.05% vs. 94.13%, *p* = 0.057). However, a higher proportion of patients with higher lactate levels have septic shock (63.29%vs. 70.24%, *p* = 0.002).Table 1Baseline characteristics, vital signs, laboratory parameters and outcomes of patients with sepsisLactate group 1Lactate group 2TotalPNumber11666991865Baseline variables Age70 (56--80)66 (55.5--77)68 (56--78.25)0.057 Sex (%)Female502 (43.05)300 (42.92)802 (43.00)0.955Male664 (56.95)399 (57.08)1063 (57.00) Ethnicity (%)White883 (71.43)473 (67.67)1356 (72.71)\< 0.001Black94 (8.06)76 (10.87)170 (9.12)Yellow29 (2.49)25 (3.58)54 (2.90)Others160 (13.72)125 (17.88)285 (15.28)Admission type (%)Urgent22 (1.89)16 (2.29)38 (2.04)0.836Emergency1088 (93.31)650 (92.99)1738 (93.19)Elective56 (4.80)33 (4.72)89 (4.77)ICU stay (%)CCU94 (8.06)63 (9.01)157 (84.18)0.247CSRU65 (5.57)29 (4.15)94 (50.40)MICU705 (60.46)441 (63.09)1146 (61.45)SICU188 (16.12)114 (16.31)302 (16.19)TSICU114 (9.78)52 (7.44)166 (8.90)Vital signsHR93 (79--107.5)101 (82.5--112)96 (81--109)\< 0.001SBP106 (99--111.5)104 (95.5--112)104 (97--112)\< 0.001DBP54 (48--61)53 (49--61.5)53.5 (48.75--61)0.092MBP70 (66--76.5)68 (64--77)69.5 (65--77)0.001RR21 (19--24)23 (19.5--26)22 (19--26)\< 0.001T37 (36--37)37 (36--37)37 (36--37)\< 0.001SpO297 (95--99)97 (94--98)97 (95--99)\< 0.001Laboratory parameters (mmol/L)Hemoglobin10.2 (9.1--12.79)10.4 (9.2--11.8)10.2 (9.1--11.6)0.051Albumin2.7 (2.3--3.1)2.6 (2.2--3.1)2.6 (2.2--3.1)0.220WBC14.2 (9.2--40)13.45 (7.55--20.43)14 (8.6--20.2)0.423Bilirubin0.8 (0.4--1.8)1.35 (0.6--4.1)1 (0.5--2.5)0.001BUN35 (21--57)36.5 (22.5--78.55)35.5 (21.5--56)0.001Potassium4.1 (3.8--4.6)4.4 (3.9--4.9)4.2 (3.8--4.8)\< 0.001Sodium138.5 (135--141.38)138 (134.5--141.5)138 (135--141.5)\< 0.001Bicarbonate20.5 (18--24)17.5 (14.5--20.5)19.5 (16--22.5)\< 0.001Cr1.6 (1--2.8)1.9 (1.2--3.1)1.8 (1.08--3)\< 0.001Platelet193.5 (120.25--290.5)154 (86.5--241.25)180 (104.5--265.38)0.300Lactate2.05 (1.53--2.80)4.95 (3.90--7.35)3.23 (2.04--4.96)\< 0.001Score systemSAPS II47 (37--56)57 (46--69)50 (40--61)\< 0.001SOFA7 (5--10)11 (8--13)8 (6--11)\< 0.001GCS15 (14--15)15 (13--15)15 (13--15)0.685qSOFA (%)026 (2.23)10 (0.015)36 (1.93)\< 0.0011155 (13.29)46 (6.58)201 (10.78)2763 (65.44)486 (69.53)1249 (66.97)3222 (19.04)157 (22.46)379 (20.32)Outcome (%)30-day mortality395 (33.88)414 (59.23)809 (43.38)\< 0.00190-day mortality508 (43.57)474 (67.81)982 (52.65)\< 0.0011-year mortality600 (51.46)499 (71.39)1099 (58.93)\< 0.001Hospital mortality408 (34.99)425 (60.80)833 (44.66)\< 0.001Severe sepsis (%)1120 (96.05)658 (94.13)1778 (95.34)0.057Septic shock (%)738 (63.29)491 (70.24)1229 (65.90)0.002ICU, intensive care unit; SICU, surgical intensive care unit; CCU, cardiac care unit; CSRU, cardiac surgery recovery unit; MICU, medical intensive care unit; TSICU, Trauma surgical intensive care unit; GCS, Glasgow Coma Scale; SBP, systolic blood pressure; DBP, diastolic blood pressure; MBP, mean blood pressure; HR, heart rate; RR, respiratory rate; T, temperature; WBC, white blood cell; BUN, blood urea nitrogen; Cr, creatinine. *P* \< 0.05 means significant different

Lactate is an independent prognostic predictor in sepsis patients {#Sec8}
-----------------------------------------------------------------

Survival analysis was conducted to explore the impact of lactate on prognosis. Notably, patients in the lower lactate group had better short-term and long-term survival rates. Patients in the higher lactate group had increased 30-day, 90-day, 1-year and in-hospital mortality (Fig. [2](#Fig2){ref-type="fig"}). Furthermore, we performed univariate analysis of baseline variables (age, sex, ethnicity, admission type, and ICU type) and laboratory tests (haemoglobin, albumin, WBC, bilirubin, BUN, potassium, sodium, bicarbonate, Cr, platelets, and lactate). Age, sex, admission type, ICU type, albumin, bilirubin, BUN, potassium, bicarbonate, Cr, platelets and lactate were analysed in the univariate analysis, and the factors significantly correlated with OS were adjusted for multivariate analysis. According to the results, lactate remained an independent prognostic factor for sepsis (Table [2](#Tab2){ref-type="table"}). The Kaplan-Meier survival curves of patients with different lactate levels in different ICU types are shown in Additional file [1](#MOESM1){ref-type="media"}: Figure S1, Additional file [2](#MOESM2){ref-type="media"}: Figure S2, Additional file [3](#MOESM3){ref-type="media"}: Figure S3, Additional file [4](#MOESM4){ref-type="media"}: Figure S4. Additional file [5](#MOESM5){ref-type="media"}: Figure S5. The AUROC for qSOFA, SOFA, lactate and the AUROC for qSOFA, SOFA and lactate in different ICU types are shown in Additional file [6](#MOESM6){ref-type="media"}: Table S3 and Additional file [7](#MOESM7){ref-type="media"}: Table S4. Fig. 2Probability of mortality curve for the patient with sepsis by lactate levels. **a**. 30-day mortality; **b**. 90-day mortality; **c**. hospital mortality; **d**. 1-year mortality. *P* values were calculated using log Rank-Mantel. P\< 0.05 means statistically significantTable 2Univariate and multivariate analysis of risk factors to 30-day mortalityUnivariate analysisMultivariate analysisPHazard Ratio95.0% CIPHazard Ratio95.0% CILowerUpperLowerUpperAge\< 0.0011.5641.3601.799\< 0.0011.6371.3971.917Sex0.1701.1030.9591.2690.0271.0761.0081.148Ethnicity0.0031.0941.0311.161Admission type0.0010.6240.4740.8200.0150.6980.5220.934ICU type0.0070.9060.8430.973Hemoglobin0.0300.8580.7480.985Albumin0.0450.8620.7460.9970.0090.8130.6970.949WBC0.8961.0090.8791.158Bilirubin\< 0.0011.5761.3541.836\< 0.0011.3661.1601.607BUN\< 0.0011.8161.5762.0930.0031.2851.0861.520Potassium\< 0.0011.6721.4531.924\< 0.0011.5781.3421.855Sodium0.6190.9660.8411.108Bicarbonate\< 0.0010.6350.5530.7300.0050.7930.6740.932Cr\< 0.0011.6491.4341.897Platelet\< 0.0010.703.6120.8080.0040.7890.6710.928Lactate\< 0.0012.3042.0072.646\< 0.0011.9361.6492.271

SOFA is often used to evaluate organ dysfunction and is correlated with mortality \[[@CR1]\]. Figure [3](#Fig3){ref-type="fig"} illustrates the relationship between lactate and qSOFA/SOFA score (*r* = 0.084, *p* \< 0.001; *r* = 0.430, p \< 0.001, respectively) in patients with sepsis. Higher lactate levels correlate with higher qSOFA/SOFA scores.Fig. 3The association between lactate and SOFA score (*r* = 0.43, *P* = 0). Pearson analysis was performed

Comparison of lactate to SOFA and qSOFA scores {#Sec9}
----------------------------------------------

The Sepsis-3 criteria recommended qSOFA based on its simple bedside criteria and its ability to facilitate prompt identification of suspected infectious adult patients who are likely to have poor outcomes \[[@CR1]\]. Discrimination of 30-day mortality (Fig. [4](#Fig4){ref-type="fig"}; Table [3](#Tab3){ref-type="table"}), which was assessed by the AUROC, was significantly higher for lactate (AUROC, 0.664) than for qSOFA (AUROC, 0.547). The discriminative power of lactate was similar to that of SOFA (AUROC, 0.686). Moreover, the same trends were observed for 90-day mortality, hospital mortality and 1-year mortality (Fig. [4](#Fig4){ref-type="fig"}; Table [3](#Tab3){ref-type="table"}).Fig. 4Receiver operating characteristic curves of lactate for predicting mortality. **a**. 30-day mortality; **b**. 90-day mortality; **c**. hospital mortality; **d**. 1-year mortalityTable 3AUROC of lactate, qSOFA, SOFA for mortalityArea Under ROC curve30-day mortality (95%CI)90-day mortality (95%CI)hospital mortality (95%CI)1-year mortality (95%CI)Lactate0.664 (0.639,0.689)0.656 (0.632,0.681)0.668 (0.643,0.693)0.636 (0.611,0.661)qSOFA0.547 (0.521,0.574)0.539 (0.513,0.565)0.544 (0.518,0.571)0.541 (0.514,0.567)SOFA0.686 (0.661,0.710)0.673 (0.648,0.697)0.695 (0.671,0.719)0.653 (0.628,0.677)Lactate+qSOFA0.672 (0.647--0.697)0.661 (0.636--0.685)0.674 (0.650--0.699)0.640 (0.616--0.665)

Next, we selected the cut-off values of lactate, qSOFA, SOFA that were highly sensitive and specific in predicting short-term and long-term mortality, through ROC curve analysis. The sensitivities, specificities, positive/negative predictive values and positive/negative likelihood ratios (LR+/−) of lactate for mortality are shown in Table [4](#Tab4){ref-type="table"}. The values of LR+/− were partiallly consistent with the results reported in a previous study \[[@CR19]\].Table 4Diagnostic sensitivity, specificity, predictive values and positive/negative likelihood ratios of lactate, qSOFA, SOFA for mortalitySensitivitySpecifityPPVNPVLR+LR-Lactate0.5120.7300.5920.3391.4530.51230-day mortatilyqSOFA0.2360.8220.4960.4160.8170.481SOFA0.5450.7250.6030.3251.5210.480Lactate0.4140.8200.6690.3612.0230.56690-day mortatilyqSOFA0.2300.8270.5940.5091.1590.837SOFA0.5100.7400.6850.4242.1780.737Lactate0.4210.8290.6660.3601.9940.563hospital mortatilyqSOFA0.2340.8220.5150.4290.8560.529SOFA0.6450.6470.5950.3071.4750.443Lactate0.3940.8040.7570.5233.1171.0971-year mortatilyqSOFA0.2320.8380.6730.5681.4781.174SOFA0.4820.7380.7250.4982.6370.993PPV, Positive predictive value; NPV, Negative predictive value; LR+, Positive likelihood ratio; LR-, Negative likelihood ratio

Discussion {#Sec10}
==========

Multiple studies have explored the association between lactate levels and prognosis in critically ill patients. Lower lactate levels, and even levels in the normal range, were reported to be related to lower severity of sepsis \[[@CR12]\]. *Wacharasint* et al demonstrated that patients with lactate levels in the normal-range (between 1.4 and 2.3 mmol/L) had markedly increasing risk of organ failure and higher mortality compared with patients who had lactate levels less than 1.4 mmol/L in two cohorts \[[@CR12]\]. Sepsis-3 recommended serum lactate level \> 2 mmol/L as a major criterion for the clinically identification of septic shock \[[@CR1]\]. A lactate concentration greater than 4 mmol/L was described as having a specificity of 96% in predicting hospital mortality in non-hypotensive patients \[[@CR20]\]. A retrospective study that included 7155 ICU patients showed that a significant association between lactate concentration and increased hospital mortality was first detectable at the time weighted lactate concentration was greater than 0.75 mmol/L \[[@CR7]\]. Lactate has also used to guide resuscitation efficacy \[[@CR21]\]. At the same time, the use of qSOFA and SOFA has been endorsed by professional societies worldwide.

Recently, *Simpson* raised concerns that reliance on qSOFA or SOFA criteria may lead to delayed diagnosis and intervention in cases of serious infection \[[@CR22]\]. Furthermore, a systematic review and meta-analysis demonstrated that qSOFA was poorly sensitive and moderately specific for the risk of death \[[@CR23]\]. *Ho* \[[@CR24]\] found that qSOFA had modest mortality predictive ability in both septic and non-septic patients in a prospective study. When combined with lactate, qSOFA showed predictive ability comparable to that of SOFA. An observational cohort study that included patients with infection who were admitted in the emergency department demonstrated poor performance of qSOFA in predicting mortality \[[@CR25]\]. Therefore, we compared mortality prediction by serum lactate to mortality prediction by SOFA and qSOFA. First, we found that lactate was positively associated with qSOFA/SOFA scores (Fig. [3](#Fig3){ref-type="fig"}) and prognosis (Fig. [2](#Fig2){ref-type="fig"}). Next, lactate was shown to be an independent prognostic predictor by Cox regression model analysis (Table [2](#Tab2){ref-type="table"}). Lactate showed superior prognostic accuracy for short-term and long-term mortality compared to qSOFA, and the predictive validity of lactate was similar to that of SOFA (Table [3](#Tab3){ref-type="table"}). The AUROC of SOFA and of qSOFA combined with lactate was similar to the AUROC reported in a previous study in septic patients \[[@CR24]\]. However, in our cohort, qSOFA showed a capacity to predict mortality in patients with an AUROC lower than that found in Ho's study \[[@CR24]\]. qSOFA had far less sensitivity, but similar specificity to lactate and SOFA (Table [4](#Tab4){ref-type="table"}). Combining lactate with qSOFA yielded a predictive ability close to that of the SOFA score alone (Table [3](#Tab3){ref-type="table"}).

Some studies revealed that the qSOFA score is associated with hospital mortality and that it present higher prognostic accuracy than the SIRS score in adults with suspected infection \[[@CR14], [@CR26]\]. The task force of Sepsis-3 suggested using qSOFA to assess organ dysfunction due to its convenience, rapid performance and repeatability. Lactate was not included as an indicator of illness severity. However, a recent study suggested that lactate reduction in the first day of ICU admission is correlated with improved outcome of septic patients regardless of the haemodynamic status \[[@CR27]\]. Our study revealed that the sensitivity of qSOFA was low, although it showed relatively high specificity. Lactate testing is a simple, inexpensive, and reasonably sensitive tool for predicting mortality and is more stable than qSOFA when sedation is used. Lactate levels correlated significantly with the SOFA scores. This is consistent with existing studies \[[@CR28]--[@CR30]\]. High lactate can be considered a warning signal for organ dysfunction and is a signal for urgent medical intervention. In fact, high sensitivity may be superior to specificity in the context of fatal sepsis.

Although lactate was reported to guide resuscitation efficacy \[[@CR21]\], multicentre, randomized trials indicated that fluid resuscitation was not beneficial to septic shock patients with or without hyperlactataemia \[[@CR31], [@CR32]\]. Moreover, fluid resuscitation and lactate clearance might be harmful when hyperlactataemia is not caused by hypoperfusion \[[@CR5]\]. However, high lactate levels should be interpreted in accordance with the patient's specific circumstances.

Our study has several limitations. This study is not prospective but retrospective. The inherent bias of retrospective studies could not be avoided. Lactate demonstrated low sensitivity and moderate specificity for short- and long-term mortality in septic patients. Lactate alone would not be a good predictive test of mortality. Approximately half of the adult sepsis patients in the database were excluded due to lack of laboratory testing; the significant number of excluded patients may affect our conclusion. In addition, because the data were collected from different types of ICUs, the heterogeneity of treatment further complicates the interpretation of the results. Previous studies have established that early lactate levels are associated with organ dysfunctions and mortality in the ICU and emergency departments \[[@CR10], [@CR33]--[@CR35]\]. Delays in lactate measurement are correlated with increased mortality of septic patients \[[@CR36]\]. However, in our cohort, the time that elapsed between the first lactate measurement and the onset of sepsis was inconsistent, and the time at which the patient's lactate was measured in the first 24 h was also inconsistent. Although we used the 24-h average lactate levels to eliminate the bias, the levels might be influenced by resuscitation of the patients, and the average lactate levels may not reflect the true resuscitation state of the patients. Additionally, interventions that might affect SOFA scores, qSOFA scores and prognosis were not included in the study, and lack of these data may affect the analysis. It is difficult to assess the impact of the change in the definition of sepsis on our results due to the de-identification process of the data in the database. Prospective studies need to be conducted, and better outcome predictors need to be further explored.

Conclusions {#Sec11}
===========

In addition to its simplicity and accuracy, lactate is a better prognostic factor than qSOFA and SOFA in adult patients with sepsis. Further study is needed given that this work is based on retrospective data and that the timing of lactate determination in this study may affect results obtained.
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